COVID-19 Vaccine-Related Myocarditis: A Descriptive Study of 40 Case Reports

After the surging rise in the Coronavirus disease 2019 (COVID-19) pandemic, the Food and Drug Administration (FDA) approved emergency approval of vaccinations to prevent life-threatening complications of COVID-19 infection. These vaccines are BNT162b2, mRNA-1273. Later, the FDA also approved JNJ-784...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia Hong, Ikwuanusi, Ifeanyi A, Bommu, Veera Jayasree Latha, Patel, Vraj, Aujla, Harpreet, Kaushik, Vishrut, Cheriyath, Pramil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887934/
https://www.ncbi.nlm.nih.gov/pubmed/35251812
http://dx.doi.org/10.7759/cureus.21740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887934/
https://www.ncbi.nlm.nih.gov/pubmed/35251812
http://dx.doi.org/10.7759/cureus.21740

Ejemplares similares